We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
AVTX | Avalo Therapeutics Inc | 20.66 | 15.91 | 334.95% | 2,230,746 |
XLO | Xilio Therapeutics Inc | 1.9801 | 1.34 | 209.87% | 9,117,790 |
AKAN | Akanda Corporation | 0.315 | 0.1501 | 91.02% | 16,074,349 |
PIK | Kidpik Corporation | 6.19 | 2.92 | 89.30% | 4,062,329 |
BCG | Binah Capital Group Inc | 15.8115 | 6.31 | 66.44% | 191,583 |
PEGR | Project Energy Reimagined Acquisition Corporation | 11.58 | 2.92 | 33.72% | 484 |
BDRX | Biodexa Pharmaceuticals PLC | 1.10 | 0.241 | 28.06% | 1,699,519 |
CRVO | CervoMed Inc | 25.12 | 5.50 | 28.03% | 7,281 |
MTEM | Molecular Templates Inc | 2.87 | 0.51 | 21.61% | 145,024 |
ATLX | Atlas Lithium Corporation | 18.00 | 3.08 | 20.64% | 16,628 |
KTRA | Kintara Therapeutics Inc | 0.1078 | 0.0183 | 20.45% | 18,274,076 |
Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.
Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.
SAN DIEGO, March 27, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the expansion of the inclusion criteria in the open label 15- patient REM-001 study in cutaneous metastatic breast cancer (CMBC) to include patients receiving pembrolizumab (KEYTRUDA®) for at least three months at screening.
ZEELAND, Mich., March 27, 2024 /PRNewswire/ -- MillerKnoll Inc. (NASDAQ: MLKN) today reported results for the third quarter of fiscal year 2024, which ended March 2, 2024.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 70,717.95 | 1,253.38 | 1.80% | 1.39T | 7,581,295,332 |
ETH | Ethereum | 3,564.49 | 64.43 | 1.84% | 429.36B | 3,898,383,195 |
USDT | Tether USD | 0.99942 | -0.00002 | 0.00% | 97.78B | 1,033,665,059 |
BNB | Binance Coin | 581.30 | 7.18 | 1.25% | 92.16B | 514,650,269 |
SOL | Solana | 183.71 | -2.41 | -1.29% | 81.12B | 1,683,514,224 |
STETH | stETH | 3,554.97 | 90.54 | 2.61% | 34.94B | 13,012,474 |
XRP | Ripple | 0.6196 | 0.0081 | 1.32% | 33.87B | 562,150,306 |
DOGE | Dogecoin | 0.21558 | 0.02554 | 13.44% | 31.06B | 2,845,453,404 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 1,433,361,766 |
ADA | Cardano | 0.6465 | -0.0011 | -0.17% | 22.77B | 191,258,307 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions